Clinical Usefulness of an Intraoperative “Quick Parathyroid Hormone” Measurement in Primary Hyperparathyroidism Management

  • Serpil Salman
  • Fatih Tunca


Hypercalcemia was detected in an elderly female presenting with psychological symptoms. Primary hyperparathyroidism was diagnosed according to laboratory results. Normal serum calcium (Ca) levels were restored following hydration and the administration of furosemide and zoledronic acid. However, parathyroidectomy was required. Because of poor health, minimally invasive parathyroidectomy was the preferred method, requiring adenoma localization. Neck ultrasonography (USG) revealed a suspicious mass in the inferoposterior region of the right thyroid lobe that can be a parathyroid adenoma. Scintigraphic imaging could not be performed to confirm the USG findings because of poor health. Intraoperative parathyroid hormone assay (quick PTH) was scheduled. During the operation, following the removal of the mass revealed on USG findings, PTH levels decreased from 579 to 50.8 pg/mL. On follow-up, serum Ca, phosphate, and PTH levels remained in the normal range, and cognitive impairment gradually improved.


Parathyroid Adenoma Hypercalcemia Quick PTH Parathyroidectomy Minimally invasive parathyroidectomy Cognitive impairment 


  1. 1.
    Khosla S. Hypercalcemia and hypocalcemia. In: Jameson JL, editor. Harrison’s endocrinology. New York: Mc Graw Hill Education; 2017. p. 442–5.Google Scholar
  2. 2.
    Sankaran S, Gamble G, Bolland M, Reid IR, Grey A. Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab. 2010;95:1653–62. Scholar
  3. 3.
    Trombetti A, Christ ER, Henzen C, Gold G, Brändle M, Herrmann FR, et al. Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss primary hyperparathyroidism cohort: a focus on neuro-behavioral and cognitive symptoms. J Endocrinol Investig. 2016;39:567–76. Scholar
  4. 4.
    Dotzenrath CM, Kaetsch AK, Pfingsten H, Cupisti K, Weyerbrock N, Vossough A, et al. Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World J Surg. 2006;30(5):680. Scholar
  5. 5.
    Marcocci C, Bollerslev J, Khan AA, Shoback DM. Medical management of primary hyperparathyroidism: proceedings of the fourth international workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2014;99:3607–18. Scholar
  6. 6.
    Misiorowski W, Zgliczyński W. Cinacalcet as symptomatic treatment of hypercalcaemia in primary hyperparathyroidism prior to surgery. Endokrynol Pol. 2017;68:306–10. Scholar
  7. 7.
    Thomas DC, Roman SA, Sosa JA. Parathyroidectomy in the elderly: analysis of 7313 patients. J Surg Res. 2011;170:240–6. Scholar
  8. 8.
    Denizot A, Grino M, Oliver C. Surgical management of primary hyperparathyroidism in older adults. J Am Geriatr Soc. 2014;62:1759–63. Scholar
  9. 9.
    Borley NR, Collins RE, O'Doherty M, Coakley A. Technetium-99m sestamibi parathyroid localization is accurate enough for scan-directed unilateral neck exploration. Br J Surg. 1996;83:989–91.CrossRefGoogle Scholar
  10. 10.
    Van Husen R, Kim LT. Accuracy of surgeon-performed ultrasound in parathyroid localization. World J Surg. 2004;28:1122–6.CrossRefGoogle Scholar
  11. 11.
    Lumachi F, Zucchetta P, Marzola MC, Boccagni P, Angelini F, Bui F, et al. Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol. 2000;143:755–60.CrossRefGoogle Scholar
  12. 12.
    Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28:1–19. Scholar
  13. 13.
    Udelsman R, Akerström G, Biagini C, Duh QY, Miccoli P, Niederle B, et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3595–606. Scholar
  14. 14.
    Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W. Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbeck’s Arch Surg. 2009;394:843–9. Scholar
  15. 15.
    Nair CG, Babu MJ, Jacob P, Menon R, Mathew J. Is intraoperative parathyroid hormone monitoring necessary in symptomatic primary hyperparathyroidism with concordant imaging? Indian J Endocrinol Metab. 2016;20:512–6. Scholar
  16. 16.
    Kim HG, Kim WY, Woo SU, Lee JB, Lee YM. Minimally invasive parathyroidectomy with or without intraoperative parathyroid hormone for primary hyperparathyroidism. Ann Surg Treat Res. 2015;89:111–6. Scholar
  17. 17.
    Bobanga ID, McHenry CR. Is intraoperative parathyroid hormone monitoring necessary for primary hyperparathyroidism with concordant preoperative imaging? Am J Surg. 2017;213:484–8. Scholar
  18. 18.
    Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg. 2002;236:543–51.CrossRefGoogle Scholar
  19. 19.
    Zhao J, Yao L, Wang C, Sun Y, Sun Z. The effects of cognitive intervention on cognitive impairments after intensive care unit admission. Neuropsychol Rehabil. 2017;27:301–17. Scholar
  20. 20.
    Pross N. Effects of dehydration on brain functioning: a life-span perspective. Ann Nutr Metab. 2017;70:30–6. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Serpil Salman
    • 1
  • Fatih Tunca
    • 2
  1. 1.Istinye University Medical Faculty, Department of Internal MedicineIstanbulTurkey
  2. 2.Istanbul University Medical Faculty, Department of General SurgeryIstanbulTurkey

Personalised recommendations